Guru Ownership Trend
Guru Analysis for Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $176.46 M.
Top institutional holders include Catherine Wood and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $6.92 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 101.0%. Conversely, Paul Tudor Jones reduced exposure by 52.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Intellia Therapeutics, Inc. (NTLA)
Major holders include Catherine Wood ($186.01 M), Cliff Asness ($8.08 M), Steven Cohen ($3.46 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 15.51 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $6.92 M, with 4 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited NTLA. The total reported sell value was $18.33 M.
Yes, 2 managers opened new positions in NTLA, and 2 increased their existing holdings. The total reported buy value was $11.41 M.